Comparative Tolerability of First-Generation Selective Estrogen Receptor Modulators in Breast Cancer Treatment and Prevention

Author： Curtis M.G.  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.24, Iss.14, 2001-01, pp. : 1039-1053

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The First Organometallic Selective Estrogen Receptor Modulators (SERMs) and Their Relevance to Breast Cancer

By  

Current Medicinal Chemistry, Vol. 11, Iss. 18, 2004-09 ,pp. : 2505-2517

Bentham Science Publishers

Access to resources Recommend Favorite

Selective Estrogen Receptor Modulators and Aromatase Inhibitors for Breast Cancer Chemoprevention

By  

Current Drug Targets, Vol. 12, Iss. 13, 2011-12 ,pp. : 1874-1887

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Selective Estrogen Receptor Modulators for Breast Cancer

By  

Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 10, 2009-09 ,pp. : 1191-1201

Bentham Science Publishers

Access to resources Recommend Favorite

Development of selective aryl hydrocarbon receptor modulators for treatment of breast cancer

By Safe S.   Qin C.   McDougal A.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 9, 1999-09 ,pp. : 1385-1396

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics of Selective Estrogen Receptor Modulators

By Morello K.C.   Wurz G.T.   DeGregorio M.W.  

Clinical Pharmacokinetics, Vol. 42, Iss. 4, 2003-01 ,pp. : 361-372

Adis International

Access to resources Recommend Favorite